Survivin as a universal tumor antigen for novel cancer immunotherapy: functions of a killer clone.
- 1 December 2008
- journal article
- comment
- Published by Taylor & Francis Ltd in Cancer Biology & Therapy
- Vol. 7 (12), 1888-9
- https://doi.org/10.4161/cbt.7.12.7219